ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, Paige E., Cirrito, John R., Wesson, Daniel W., Lee, C. Y. Daniel, Karlo, J. Colleen, Zinn, Adriana E., Casali, Brad T., Restivo, Jessica L., Goebel, Whitney D., James, Michael J., Brunden, Kurt R., Wilson, Donald A., Landreth, Gary E.·2012·Science

DOI 10.1126/science.1217697

Cited by (1,000)

Items 301–400 of 1,000

Apolipoprotein E lipoprotein particles inhibit amyloid-β uptake through cell surface heparan sulphate proteoglycan
Fu, Yuan, Zhao, Jing, Atagi, Yuka, Nielsen, Henrietta M., Liu, Chia-Chen, Zheng, Honghua, Shinohara, Mitsuru, Kanekiyo, Takahisa, Bu, Guojun · 2016 · Molecular Neurodegeneration
A randomized controlled study to evaluate the effect of bexarotene on amyloid‐β and apolipoprotein E metabolism in healthy subjects
Ghosal, Kaushik, Haag, Michael, Verghese, Philip B., West, Tim, Veenstra, Tim, Braunstein, Joel B., Bateman, Randall J., Holtzman, David M., Landreth, Gary E. · 2016 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Biological Hallmarks of Cancer in Alzheimer’s Disease
Kelly Nicole Holohan Nudelman, Brenna C. McDonald, Debomoy K. Lahiri, Andrew J. Saykin · 2019 · Molecular Neurobiology
Biological applications of near infrared fluorescence dye probes in monitoring Alzheimer’s disease
Yusif Issahak Gyasi, Yipeng Pang, Xinrui Li, Jing-xue Gu, Xiaojing Cheng, Jiao Liu, Ting Xu, Yi Liu · 2019 · European Journal of Medicinal Chemistry
A multitude of signaling pathways associated with Alzheimer's disease and their roles in AD pathogenesis and therapy
Kundlik Gadhave, Deepak Kumar, Vladimir Nikolaevich Uversky, Rajanish Giri · 2020 · Medicinal Research Reviews
Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion
Jacob Ellegood, Sander Markx, Jason P. Lerch, Patrick E. Steadman, C Genç, Frank A. Provenzano, Steven A. Kushner, R. Mark Henkelman, Maria Karayiorgou, Joseph A. Gogos · 2013 · Molecular Psychiatry
CSF Apo-E levels associate with cognitive decline and MRI changes
For the Alzheimer’s Disease Neuroimaging Initiative, Toledo, Jon B., Da, Xiao, Weiner, Michael W., Wolk, David A., Xie, Sharon X., Arnold, Steven E., Davatzikos, Christos, Shaw, Leslie M., Trojanowski, John Q. · 2014 · Acta Neuropathologica
EGFR is a potential dual molecular target for cancer and Alzheimer’s disease
Hee-Jeong Choi, Yoo Joo Jeong, Jieun Kim, Hyang‐Sook Hoe · 2023 · Frontiers in Pharmacology
The emerging role of bexarotene in the treatment of Alzheimer’s disease: current evidence
Tousi, Babak · 2015 · Neuropsychiatric Disease and Treatment
The Role of Cholesterol Metabolism in Alzheimer’s Disease
Sun, Jia-Hao, Yu, Jin-Tai, Tan, Lan · 2015 · Molecular Neurobiology
Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How
Lewandowski, Cutler T., Maldonado Weng, Juan, LaDu, Mary Jo · 2020 · Neurobiology of Disease
Bexarotene Blocks Calcium-Permeable Ion Channels Formed by Neurotoxic Alzheimer’s β-Amyloid Peptides
Jacques Fantini, Coralie Di Scala, Nouara Yahi, Jean‐Denis Troadec, Kevin Sadelli, Henri Chahinian, Nicolas Garmy · 2014 · ACS Chemical Neuroscience
Early hyperactivity in lateral entorhinal cortex is associated with elevated levels of AβPP metabolites in the Tg2576 mouse model of Alzheimer's disease
Wenjin Xu, Shane M. Fitzgerald, Ralph A. Nixon, Efrat Levy, Donald A. Wilson · 2014 · Experimental Neurology
ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations
Johnson, Lance A, Zuloaga, Damian G, Bidiman, Erin, Marzulla, Tessa, Weber, Sydney, Wahbeh, Helane, Raber, Jacob · 2015 · Neuropsychopharmacology
PPARδ activation by bexarotene promotes neuroprotection by restoring bioenergetic and quality control homeostasis
Audrey S. Dickey, Dafne N. Sanchez, Martin Arreola, Kunal R. Sampat, Weiwei Fan, Nicolas Arbez, Sergey Akimov, Michael J. Van Kanegan, Kohta Ohnishi, Stephen K. Gilmore-Hall et al. · 2017 · Science Translational Medicine
Massively parallel C. elegans tracking provides multi-dimensional fingerprints for phenotypic discovery
Michele Perni, Pavan K. Challa, Julius B. Kirkegaard, Ryan Limbocker, Mandy Koopman, Maarten C. Hardenberg, Pietro Sormanni, Thomas H. Müller, Kadi Liis Saar, Lianne W. Y. Roode et al. · 2018 · Journal of Neuroscience Methods
Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
Fitz, Nicholas F., Wolfe, Cody M., Playso, Brittany E., Biedrzycki, Richard J., Lu, Yi, Nam, Kyong Nyon, Lefterov, Iliya, Koldamova, Radosveta · 2020 · Molecular Neurodegeneration
One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina
Vivek Gupta, Veer B. Gupta, Nitin Chitranshi, Sumudu V. S. Gangoda, Roshana Vander Wall, Mojdeh Abbasi, Mojtaba Golzan, Yogita Dheer, Tejal M. Shah, Alberto P. Avolio et al. · 2016 · Cellular and Molecular Life Sciences
Amyloid β-interacting partners in Alzheimer's disease: From accomplices to possible therapeutic targets
Han, Sun-Ho, Park, Jong-Chan, Mook-Jung, Inhee · 2016 · Progress in Neurobiology
Transcriptional regulation and its misregulation in Alzheimer’s disease
Xiao‐Fen Chen, Yun‐wu Zhang, Huaxi Xu, Guojun Bu · 2013 · Molecular Brain
C/EBPβ is a key transcription factor for APOE and preferentially mediates ApoE4 expression in Alzheimer’s disease
Yiyuan Xia, Zhi-Hao Wang, Jichun Zhang, Xia Liu, Shan Ping Yu, Karen X. Ye, Jian–Zhi Wang, Keqiang Ye, Xiaochuan Wang · 2020 · Molecular Psychiatry
Targeting Nuclear Receptors in Neurodegeneration and Neuroinflammation
Sabine Willems, Daniel Zaienne, Daniel Merk · 2021 · Journal of Medicinal Chemistry
On the central role of brain connectivity in neurodegenerative disease progression
Yasser Iturria‐Medina, Alan Charles Evans · 2015 · Frontiers in Aging Neuroscience
The NR4A orphan nuclear receptors mediate transcription-dependent hippocampal synaptic plasticity
Bridi, Morgan S., Abel, Ted · 2013 · Neurobiology of Learning and Memory
Activation of RXR/PPARγ underlies neuroprotection by bexarotene in ischemic stroke
Michelangelo Certo, Yasuyuki Endo, Kiminori Ohta, Shinobu Sakurada, Giacinto Bagetta, Diana Amantea · 2015 · Pharmacological Research
ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice
Angela W. Corona, Nathan Kodoma, Brad T. Casali, Gary E. Landreth · 2015 · Journal of Neuroimmune Pharmacology
Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression
Nikolaos Volakakis, Katarína Tiklová, Mickaël Decressac, Maria Papathanou, Bengt Mattsson, Linda Gillberg, André Nobre, Anders Björklund, Thomas Perlmann · 2015 · Journal of Neuroscience
Blood metabolite markers of cognitive performance and brain function in aging
Brittany N. Simpson, Min Gyu Kim, Yi‐Fang Chuang, Lori L. Beason‐Held, Melissa H. Kitner‐Triolo, Michael A. Kraut, Seth T. Lirette, B. Gwen Windham, Michael E Griswold, Cristina Legido‐Quigley et al. · 2015 · Journal of Cerebral Blood Flow & Metabolism
Bexarotene protects against traumatic brain injury in mice partially through apolipoprotein E
Jianjun Zhong, Chongjie Cheng, Han Liu, Zhijian Huang, Yue Wu, Zhipeng Teng, Junchi He, Hongrong Zhang, Jinchuan Wu, Fang Cao et al. · 2016 · Neuroscience
Bexarotene-Activated Retinoid X Receptors Regulate Neuronal Differentiation and Dendritic Complexity
Mounier, A., Georgiev, D., Nam, K. N., Fitz, N. F., Castranio, E. L., Wolfe, C. M., Cronican, A. A., Schug, J., Lefterov, I., Koldamova, R. · 2015 · Journal of Neuroscience
APOE and dementia – resequencing and genotyping in 105,597 individuals
Rasmussen, Katrine L., Tybjærg‐Hansen, Anne, Nordestgaard, Børge G., Frikke‐Schmidt, Ruth · 2020 · Alzheimer's & Dementia
An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice
Jeffrey L. Frost, Bin Liu, Jens‐Ulrich Rahfeld, Martin Kleinschmidt, Brian O’Nuallain, Kevin X. Le, Inge Lues, Barbara J. Caldarone, Stephan Schilling, Hans‐Ulrich Demuth et al. · 2015 · Neurobiology of Aging
Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: potential drug to treat Alzheimer’s disease
Yuyou Zhu, Juan Wang · 2015 · Neurological Sciences
Anti-inflammatory Signaling in Microglia Exacerbates Alzheimer’s Disease-Related Pathology
Jean-Philippe Michaud, Serge Rivest · 2015 · Neuron
Current and future implications of basic and translational research on amyloid-β peptide production and removal pathways
Christopher Böhm, F. Chen, Jean Sévalle, Seema Qamar, Roger B. Dodd, Y. Li, Gerold Schmitt‐Ulms, Paul E. Fraser, Peter St George‐Hyslop · 2015 · Molecular and Cellular Neuroscience
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease
Cao, Yuan, Zhao, Lin-Wei, Chen, Zi-Xin, Li, Shao-Hua · 2024 · Frontiers in Neuroscience
Bexarotene reduces network excitability in models of Alzheimer's disease and epilepsy
Valerie C. Bomben, Jerrah K. Holth, John G. Reed, Paige E. Cramer, Gary E. Landreth, Jeffrey L. Noebels · 2014 · Neurobiology of Aging
Evidence of oxidative stress and mitochondrial dysfunction in spinocerebellar ataxia type 2 (SCA2) patient fibroblasts: Effect of coenzyme Q10 supplementation on these parameters
Nanna Cornelius, Jonathan Henry Wardman, Iain Parry Hargreaves, Viruna Neergheen, Anne Sigaard Bie, Zeynep Tümer, Jørgen Erik Nielsen, Troels T. Nielsen · 2017 · Mitochondrion
Peripheral versus central nervous system APOE in Alzheimer’s disease: Interplay across the blood-brain barrier
Dustin Chernick, Stephanie Ortiz‐Valle, Angela Jeong, Wenhui Qu, Ling Li · 2019 · Neuroscience Letters
Microglial Function and Regulation during Development, Homeostasis and Alzheimer’s Disease
Brad T. Casali, Erin G. Reed-Geaghan · 2021 · Cells
The small HDL particle hypothesis of Alzheimer's disease
Ashley E. Martinez, Gali H. Weissberger, Zsuzsanna Kuklenyik, Xulei He, Cristiana Joy Meuret, Trusha Parekh, Jon C. Rees, Bryan A. Parks, Michael S. Gardner, Sarah M. King et al. · 2022 · Alzheimer s & Dementia
Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease
Brad T. Casali, Angela W. Corona, Monica M. Mariani, J. Colleen Karlo, K. Ghosal, Gary E. Landreth · 2015 · Journal of Neuroscience
Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion
Gjumrakch Aliev, Mark E. Obrenovich, Shams S. M. Tabrez, Nasimudeen R. Jabir, V. Prakash Reddy, Yi Li, Geoffrey Burnstock, Ramón Cacabelos, Mohammad Amjad Kamal · 2013 · Oxidative Medicine and Cellular Longevity
Age- and time-dependent model of the prevalence of non-communicable diseases and application to dementia in Germany
Ralph Brinks, Sandra Landwehr · 2013 · Theoretical Population Biology
Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease
Subbiah Pugazhenthi · 2017 · Progress in molecular biology and translational science
Liver X receptors: Emerging therapeutic targets for Alzheimer's disease
Sodhi, Rupinder K., Singh, Nirmal · 2013 · Pharmacological Research
Intracellular accumulation of aggregated pyroglutamate amyloid beta: convergence of aging and Aβ pathology at the lysosome
Line De Kimpe, Elise S. van Haastert, Archontia Kaminari, Rob Zwart, Helma Rutjes, Jeroen J.M. Hoozemans, Wiep Scheper · 2012 · AGE
Cancer Chemotherapy Related Cognitive Impairment and the Impact of the Alzheimer’s Disease Risk Factor APOE
Harvey R. Fernandez, Ashima Varma, Sarah A. Flowers, George William Rebeck · 2020 · Cancers
Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation
Hu, Zhangxue, Huang, Songmin, Wu, Yu, Liu, Yunqiang, Liu, Xiaoxia, Su, Dan, Tao, Ye, Fu, Ping, Zhang, Xiuhui, Peng, Ziying et al. · 2014 · Kidney International
Dual-function triazole–pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation
Michael R. Jones, E.L. Service, J. R. Thompson, Michael C. P. Wang, Isaac J. Kimsey, Alaina S. DeToma, Ayyalusamy Ramamoorthy, Mi Hee Lim, Tim Storr · 2012 · Metallomics
Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer’s Disease (3xTg-AD)
Tuan Nguyen Minh, Agnès Dodacki, Waël Alata, Frédéric Calon, Sophie Nicolic, Jean‐Michel Scherrmann, Robert Farinotti, Fanchon Bourasset · 2015 · Journal of Alzheimer s Disease
Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease
Xiaodong Shi, Kai Sun, Rui Hu, Xiao-Ya Liu, Qiu‐Mei Hu, Xiaoyu Sun, Bin Yao, Nan Sun, Jing‐Ru Hao, Pan Wei et al. · 2016 · Journal of Neuroscience
Be positive about negatives–recommendations for the publication of negative (or null) results
Bespalov, Anton, Steckler, Thomas, Skolnick, Phil · 2019 · European Neuropsychopharmacology
Beta-Amyloid and Tau-Protein: Structure, Interaction, and Prion-Like Properties
Olga G. Tatarnikova, М. А. Орлов, Natalia V. Bobkova · 2015 · Biochemistry (Moscow)
Spectroscopic Signature for Stable β-Amyloid Fibrils versus β-Sheet-Rich Oligomers
Justin P. Lomont, Kacie L. Rich, Michał Maj, Jia-Jung Ho, Joshua S. Ostrander, Martin T. Zanni · 2017 · The Journal of Physical Chemistry B
Effects of Baicalein on Cortical Proinflammatory Cytokines and the Intestinal Microbiome in Senescence Accelerated Mouse Prone 8
Li Gao, Jiaqi Li, Yuzhi Zhou, Xudong Huang, Xuemei Qin, Guanhua Du · 2018 · ACS Chemical Neuroscience
Glutamatergic Transmission Aberration: A Major Cause of Behavioral Deficits in a Murine Model of Down's Syndrome
Kaur, Gurjinder, Sharma, Ajay, Xu, Wenjin, Gerum, Scott, Alldred, Melissa J., Subbanna, Shivakumar, Basavarajappa, Balapal S., Pawlik, Monika, Ohno, Masuo, Ginsberg, Stephen D. et al. · 2014 · The Journal of Neuroscience
Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s Disease
Troy T. Rohn · 2013 · International Journal of Molecular Sciences
Tuning Nuclear Receptor Selectivity of Wy14,643 towards Selective Retinoid X Receptor Modulation
Julius Carl Pollinger, Leonie Gellrich, Simone Schierle, Whitney Kilu, Jurema Schmidt, Lena Kalinowsky, Julia Ohrndorf, Astrid Kaiser, Jan Heering, Ewgenij Proschak et al. · 2019 · Journal of Medicinal Chemistry
Molecular Signaling Mechanisms of Natural and Synthetic Retinoids for Inhibition of Pathogenesis in Alzheimer’s Disease
Chakrabarti, Mrinmay, McDonald, Alexander J., Will Reed, J., Moss, Melissa A., Das, Bhaskar C., Ray, Swapan K. · 2016 · Journal of Alzheimer's Disease
Connecting the Dots Between Hypercholesterolemia and Alzheimer’s Disease: A Potential Mechanism Based on 27-Hydroxycholesterol
Mingan Wu, Yingying Zhai, Xiaoyi Liang, Wei‐Chun Chen, Ruiyi Lin, Linlin Ma, Yi Huang, Di Zhao, Yong Liang, Wei Zhao et al. · 2022 · Frontiers in Neuroscience
Rescuing effects of RXR agonist bexarotene on aging-related synapse loss depend on neuronal LRP1
Masaya Tachibana, Mitsuru Shinohara, Yu Yamazaki, Chia‐Chen Liu, Justin T. Rogers, Guojun Bu, Takahisa Kanekiyo · 2015 · Experimental Neurology
Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
Alexey M. Petrov, Marat R. Kasimov, Andrey Lvovich Zefirov · 2017 · Acta Naturae
Gene co-expression networks identify Trem2 and Tyrobp as major hubs in human APOE expressing mice following traumatic brain injury
Emilie L. Castranio, Anaïs Mounier, Cody M. Wolfe, Kyong Nyon Nam, Nicholas Francis Fitz, Florent Letronne, Jonathan Schug, Radosveta P. Koldamova, Iliya M. Lefterov · 2017 · Neurobiology of Disease
Neuroprotective Effect of Bexarotene in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis
Javier Riancho, María Ruiz‐Soto, Maria Teresa Berciano, José Berciano, Miguel Lafarga · 2015 · Frontiers in Cellular Neuroscience
Epigenetic Treatment of Neurodegenerative Disorders: Alzheimer and Parkinson Diseases
Michael H. Irwin, Walter H. Moos, Douglas V. Faller, Kosta Steliou, Carl A. Pinkert · 2016 · Drug Development Research
Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier
Kuntz, Mélanie, Candela, Pietra, Saint-Pol, Julien, Lamartinière, Yordenca, Boucau, Marie-Christine, Sevin, Emmanuel, Fenart, Laurence, Gosselet, Fabien · 2015 · Journal of Alzheimer's Disease
Role of Liver X Receptor in AD Pathophysiology
Adrián Gabriel Sandoval-Hernández, Luna Buitrago, Herman Moreno, Gloria Patricia Cardona‐Gómez, Gonzálo Arboleda · 2015 · PLoS ONE
Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology
Jianping Guo, Ji Cheng, Brian J. North, Wenyi Wei · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation
Miguel Moutinho, Juan Francisco Codocedo, Shweta S. Puntambekar, Gary E. Landreth · 2018 · The Annual Review of Pharmacology and Toxicology
Emerging role of HDL in brain cholesterol metabolism and neurodegenerative disorders
Turri, Marta, Marchi, Cinzia, Adorni, Maria Pia, Calabresi, Laura, Zimetti, Francesca · 2022 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Amyloid Beta Inhibits Olfactory Bulb Activity and the Ability to Smell
Reynaldo Alvarado-Martínez, Karla Salgado-Puga, Fernando Peña‐Ortega · 2013 · PLoS ONE
1,25-Dihydroxyvitamin D and Klotho
Mark R. Haussler, G. Kerr Whitfield, Carol A. Haussler, Marya S. Sabir, Zainab Khan, Ruby Sandoval, Peter W. Jurutka · 2016 · Vitamins and hormones
Interleukin-1β Drives Cellular Senescence of Rat Astrocytes Induced by Oligomerized Amyloid β Peptide and Oxidative Stress
Dongsheng Shang, Yin Hong, Wangwang Xie, Zhigang Tu, Jun Liang Xu · 2020 · Frontiers in Neurology
L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer’s disease via activating dopamine D1 receptor/PKA signaling pathway
Hao, J-R, Sun, N, Lei, L, Li, X-Y, Yao, B, Sun, K, Hu, R, Zhang, X, Shi, X-D, Gao, C · 2015 · Cell Death & Disease
Traumatic Brain Injury, Microglia, and Beta Amyloid
Rebekah Mannix, Michael J. Whalen · 2012 · International Journal of Alzheimer s Disease
Daidzein Augments Cholesterol Homeostasis via ApoE to Promote Functional Recovery in Chronic Stroke
Eunhee Kim, Moon-Sook Woo, Luye Qin, Thong Chi Ma, Cesar Beltran, Yi Bao, Jason A. Bailey, Dale Corbett, Rajiv R. Ratan, Debomoy K. Lahiri et al. · 2015 · Journal of Neuroscience
Alzheimer's disease: Only prevention makes sense
José Viña, Jorge Sanz‐Ros · 2018 · European Journal of Clinical Investigation
High‐density lipoprotein mimetic peptide 4F mitigates amyloid‐β‐induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia
Chernick, Dustin, Ortiz‐Valle, Stephanie, Jeong, Angela, Swaminathan, Suresh K., Kandimalla, Karunya K., Rebeck, G. William, Li, Ling · 2018 · Journal of Neurochemistry
The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease
Filippo Sean Giorgi, Luigi Francesco Saccaro, Alessandro Galgani, Carla Letizia Busceti, Francesca Biagioni, Alessandro Frati, Francesco Fornai · 2019 · Brain Research Bulletin
Molecular Insight into the Therapeutic Promise of TargetingAPOE4for Alzheimer’s Disease
Abdullah Al Mamun, Md. Sahab Uddin, Md. Fahim Bin Bashar, Sonia Zaman, Yesmin Begum, Israt Jahan Bulbul, Md. Siddiqul Islam, Md Shahid Sarwar, Bijo Mathew, Md. Shah Amran et al. · 2020 · Oxidative Medicine and Cellular Longevity
The Critical Role of Nurr1 as a Mediator and Therapeutic Target in Alzheimer’s Disease-related Pathogenesis
Seong Gak Jeon, Anji Yoo, Dong Wook Chun, Sang Bum Hong, Hyunju Chung, Jin-Il Kim, Minho Moon · 2020 · Aging and Disease
Striking reduction of amyloid plaque burden in an Alzheimer's mouse model after chronic administration of carmustine
Crystal D. Hayes, Debleena Dey, Juan Pablo Palavicini, Hongjie Wang, Kshitij A. Patkar, Dmitriy Minond, Adel Nefzi, Madepalli Krishnappa Lakshmana · 2013 · BMC Medicine
Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats
Gaoshang Chai, Dong-Xiao Duan, Rong-Hong Ma, Jianying Shen, Honglian Li, Zhiwei Ma, Yu Luo, Lu Wang, Xin-Hua Qi, Jian‐Zhi Wang et al. · 2014 · Neuroscience Bulletin
Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration
Goldis Malek, Eleonora Maries Lad · 2014 · Cellular and Molecular Life Sciences
Alzheimer’s disease: relevant molecular and physiopathological events affecting amyloid-β brain balance and the putative role of PPARs
Juan Manuel Zolezzi, Sussy Bastias Candia, Manuel J. Santos, Nibaldo C. Inestrosa · 2014 · Frontiers in Aging Neuroscience
Lipid transporter Spns2 promotes microglia pro‐inflammatory activation in response to amyloid‐beta peptide
Liansheng Zhong, Xue Jiang, Zhihui Zhu, Haiyan Qin, Michael B. Dinkins, Ji‐Na Kong, Silvia Leanhart, Rebecca Wang, Ahmed M. Elsherbini, Erhard Bieberich et al. · 2018 · Glia
Cooperative Therapeutic Action of Retinoic Acid Receptor and Retinoid X Receptor Agonists in a Mouse Model of Alzheimer's Disease
Kawahara, Kohichi, Suenobu, Michita, Ohtsuka, Hideyuki, Kuniyasu, Akihiko, Sugimoto, Yukihiko, Nakagomi, Madoka, Fukasawa, Hiroshi, Shudo, Koichi, Nakayama, Hitoshi · 2014 · Journal of Alzheimer's Disease
Modulation of the Aβ peptide aggregation pathway by KP1019 limits Aβ-associated neurotoxicity
Jones, Michael R., Mu, Changhua, Wang, Michael C. P., Webb, Michael I., Walsby, Charles J., Storr, Tim · 2015 · Metallomics
Small-molecule drugs development for Alzheimer's disease
Weiwei Yao, Huihui Yang, Jinfei Yang · 2022 · Frontiers in Aging Neuroscience
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer’s Disease
Anne Corbett, Gareth Haydn Williams, Clive G. Ballard · 2013 · Pharmaceuticals
Age-Dependent, Non-Cell-Autonomous Deposition of Amyloid from Synthesis of β-Amyloid by Cells Other Than Excitatory Neurons
Karthikeyan Veeraraghavalu, Can Martin Zhang, Xiaoqiong Zhang, Rudolph E. Tanzi, Sangram S. Sisodia · 2014 · Journal of Neuroscience
A Unified Hypothesis of Early- and Late-Onset Alzheimer’s Disease Pathogenesis
Craig Atwood, Richard L. Bowen · 2015 · Journal of Alzheimer s Disease
Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype
Pascal Heitel, Leonie Gellrich, Lena Kalinowsky, Jan Heering, Astrid Kaiser, Julia Ohrndorf, Ewgenij Proschak, Daniel Merk · 2019 · ACS Medicinal Chemistry Letters
Allosteric small molecule modulators of nuclear receptors
Femke A. Meijer, Iris A. Leijten-van de Gevel, Rens M. J. M. de Vries, Luc Brunsveld · 2019 · Molecular and Cellular Endocrinology
Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells
Elham Fanaee‐Danesh, Chaitanya Chakravarthi Gali, Jelena Tadić, Martina Zandl‐Lang, Alexandra Carmen Kober, Vicente Roca Agujetas, Cristina de Dios, Carmen Tam‐Amersdorfer, Anika Stracke, Nicole Maria Albrecher et al. · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Significant Upregulation of Alzheimer's β‐Amyloid Levels in a Living System Induced by Extracellular Elastin Polypeptides
Chao Ma, Juanjuan Su, Yao Sun, Yang Feng, Nolan Shen, Bo Li, Yingxia Liang, Xintong Yang, Hui Wu, Hongjie Zhang et al. · 2019 · Angewandte Chemie International Edition
In Vivo and In Vitro Effects of an Apolipoprotein E Mimetic Peptide on Amyloid-β Pathology
Shaila P. Handattu, Candyce E. Monroe, Gaurav Nayyar, Mayakonda N. Palgunachari, Inga Kadish, Thomas van Groen, G.M. Anantharamaiah, David W. Garber · 2013 · Journal of Alzheimer s Disease
Meta-Analysis of Peripheral Blood Apolipoprotein E Levels in Alzheimer’s Disease
Chong Wang, Jin‐Tai Yu, Hui-Fu Wang, Teng Jiang, Chen‐Chen Tan, Xiangfei Meng, Holly D Soares, Lan Tan · 2014 · PLoS ONE
Apolipoprotein E, amyloid-ß clearance and therapeutic opportunities in Alzheimer's disease
Adam D. Kline · 2012 · Alzheimer s Research & Therapy